InvestorsHub Logo
Followers 2
Posts 247
Boards Moderated 0
Alias Born 08/29/2018

Re: mc73 post# 30820

Friday, 10/19/2018 3:42:15 PM

Friday, October 19, 2018 3:42:15 PM

Post# of 82641
I'm would think a patented formulation with CBD, assuming the other components are not novel compounds, would not go through the very expensive and long NDA approval process. I would think it would go through the abbreviated 505 (b)(2) process. Key features of 505(b)(2)Drug Approval Pathway and Getting Cannabis Related Products Approved: The 505(b)(2) Projects